Top Markets
#1 Bitway Bitway +46.14%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.04%
#3 Pons Pons +35.97%
#4 Starpower Starpower +35.36%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.38%
#6 Ocean Protocol Ocean Protocol +20.20%
#7 SkyAI SkyAI +18.33%
#8 Mubarak Mubarak +18.32%
#9 StonkBroker StonkBroker +16.81%
#10 aelf aelf +16.32%
Coin of the day
Bitway Bitway
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
GenSight Biologics S.A. GenSight Biologics S.A.

GenSight Biologics S.A.

SIGHT
Classement en actions #29513
GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on... GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on identifying, advancing, and commercializing medical interventions for severe mitochondrial and neurodegenerative conditions affecting both the eyes and the central nervous system. Their therapeutic development leverages cutting-edge gene therapy platforms, specifically those involving mitochondrial targeting sequences and optogenetics. The company's leading drug candidate, LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, is currently undergoing Phase III clinical evaluation for treating Leber hereditary optic neuropathy (LHON) caused by a specific ND4 gene mutation. Another significant program, GS030, is engaged in Phase I/II clinical trials for retinitis pigmentosa and is also in the preclinical phase for dry age-related macular degeneration. Furthermore, GenSight Biologics is developing additional preclinical-stage programs aimed at various ophthalmic and neurodegenerative disorders. The company was founded in 2012 and maintains its headquarters in Paris, France.
Prix de l'action
$0.12952814
Capitalisation boursière
$21.11M
Changement (1 jour)
4.40%
Changement (1 an)
-35.74%
Pays
FR
Échange GenSight Biologics S.A. (SIGHT)

Catégorie

Healthcare
Historique du prix de l'action pour GenSight Biologics S.A. (SIGHT)
Prix de clôture le plus élevé : $0.11 le 2026-08-01

Prix de clôture le plus bas : $8.93 le 2016-07-01
Historique du prix de l'action de GenSight Biologics S.A. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.84%
2025 -61.96%
2024 -40.41%
2023 -85.79%
2022 -40.62%
2021 -23.84%
2020 252.34%
2019 -43.91%
2018 -36.71%
2017 -20.44%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.11 39.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 56.01%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $144.46 417.59%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.80 8.66%
CH